Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Non Operating Income: 2014-2024

Historic Non Operating Income for Theravance Biopharma (TBPH) over the last 11 years, with Dec 2024 value amounting to $4.9 million.

  • Theravance Biopharma's Non Operating Income rose 192.51% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 27.73%. This contributed to the annual value of $4.9 million for FY2024, which is 46.46% down from last year.
  • Per Theravance Biopharma's latest filing, its Non Operating Income stood at $4.9 million for FY2024, which was down 46.46% from $9.1 million recorded in FY2023.
  • Theravance Biopharma's 5-year Non Operating Income high stood at $9.1 million for FY2023, and its period low was $1.1 million during FY2021.
  • Its 3-year average for Non Operating Income is $7.5 million, with a median of $8.5 million in 2022.
  • As far as peak fluctuations go, Theravance Biopharma's Non Operating Income slumped by 66.28% in 2020, and later soared by 670.51% in 2022.
  • Yearly analysis of 5 years shows Theravance Biopharma's Non Operating Income stood at $2.8 million in 2020, then crashed by 60.83% to $1.1 million in 2021, then skyrocketed by 670.51% to $8.5 million in 2022, then increased by 6.68% to $9.1 million in 2023, then slumped by 46.46% to $4.9 million in 2024.